Pewaukee, Wisconsin, United States In 2002 was created Diamond Capital Management, which is appeared as VC. The main office of represented VC is situated in the Pewaukee. The company was established in North America in United States.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline CytoPherx, TransMolecular, NeurogesX The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Medical, Life Science. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The high activity for fund was in 2004. The fund is constantly included in less than 2 investment rounds annually. The top amount of exits for fund were in 2011. Comparing to the other companies, this Diamond Capital Management performs on 38 percentage points more the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 7 partakers. Despite the Diamond Capital Management, startups are often financed by Tullis Health Investors, TIAA, Montreux Equity Partners. The meaningful sponsors for the fund in investment in the same round are Walden International, University of North Carolina at Chapel Hill, Tullis Health Investors. In the next rounds fund is usually obtained by Walden International, SV Health Investors, ONSET Ventures.
Related Funds
| Fund Name | Location |
| CONEXIO | Japan, Sumida |
| CURAD | Central Region, Kampala, Uganda |
| DocCheck Guano AG | Cologne, Germany, Nordrhein-Westfalen |
| ESM Investment Ltd | - |
| Hellman & Friedman | California, San Francisco, United States |
| Leadout Capital | California, Palo Alto, United States |
| PICC Asset Management | China, Shanghai |
| Quintel Management Consulting | - |
| Rhapsody Venture Partners | Cambridge, Massachusetts, United States |
| Sohu.com | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
NeurogesX | $35M | 24 Feb 2004 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States | ||
NeurogesX | $35M | 24 Feb 2004 | California, United States |
